Gold Coast startup Bower raises $2M pre-seed, valued at $10M
## The Round Gold Coast startup Bower raised A$2 million in pre-seed funding led by TEN13. Admiralty Capital Group and Edale Capital participated, along with strategic angels including Yu Liu (CTO of Heidi Health), Dean Kelly, Harry Uffindell, and Emma Ferrier. One report pegs the post-money valuation at US$10 million. ## What They Ship Bower builds smart glasses for research labs. The product captures what scientists see, say, and do during experiments: observations, method changes, troubleshooting notes that normally get lost between the lab bench and formal documentation. CEO Michelle MacRae calls it "augmented research." The pitch is workflow capture at the point of creation, notafter-the-fact data entry. MacRae previously led generative AI video at Microsoft and built AI products at Dovetail and Google. Co-founder Renaud Joannes-Boyau is a geochemistry professor with 100-plus peer-reviewed papers. CTO David Lyon came from Atlassian and Xero. CRO James Boysons co-founded commerce platform EQL. That founding team composition matters: when you are selling into science-heavy organisations, credibility and domain expertise move deals. Academic co-founders signal product-market fit in a way pure tech teams cannot. ## Early Traction Early customers include Mount Sinai Hospital in New York, Mass Affinity, Bloodless Diagnostics, and Southern Cross University in northern NSW. No public revenue figures or customer count. ## The Sales Angle No hiring announcements yet, which is standard for pre-seed. Worth watching: if Bower is selling into hospitals and universities, that is long-cycle enterprise motion. Expect a technical sales team, not high-velocity SDR-led growth. The funding will go toward product development, which typically means engineering hires before sales expansion. Pre-seed at this valuation suggests they are 12 to 18 months from a proper go-to-market build-out. If they follow the standard playbook: build product, prove a handful of lighthouse customers, then hire AEs for replication. That puts potential sales hiring in mid-2027, assuming the product roadmap ships on time.